Suppr超能文献

脾边缘区淋巴瘤:一种独特的低度恶性B细胞淋巴瘤。13例临床病理研究

Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.

作者信息

Mollejo M, Menárguez J, Lloret E, Sánchez A, Campo E, Algara P, Cristóbal E, Sánchez E, Piris M A

机构信息

Department of Pathology, Hospital Virgen de la Salud, Toledo, Spain.

出版信息

Am J Surg Pathol. 1995 Oct;19(10):1146-57.

PMID:7573673
Abstract

The recognition and classification of the different varieties of splenic low-grade B-cell lymphomas have been hampered by the rarity of histological studies of surgical splenectomy specimens of B-cell lymphoma. In an effort to characterize the recently described splenic marginal zone lymphoma (SMZL), we conducted a survey of 13 patients with this type of tumor using the criteria defined by Schmid for its recognition (Schmid et al., Am J Surg Pathol 1992;16:455-66). Primary splenic high-grade lymphomas, T-cell lymphomas, and secondary infiltration by other recognized low-grade B-cell lymphomas, with the exception of splenic lymphoma with villous lymphocytes, were excluded. This selection gave rise to a homogeneous group of tumors with similar clinical, histological, immunohistochemical, and molecular features. Our study showed the critical parameters for their recognition to be morphological, including macroscopic micronodularity and the constant presence of white- and red-pulp infiltration, marginal zone pattern, and plasmacytic differentiation. No t(14;18) or PRAD-1/cyclin D1 overexpression was detect able in any case. Clinically, the tumors were widespread with a protracted evolution. Nodal infiltration by SMZL in our cases was morphologically similar to monocytoid B-cell lymphoma. SMZL could constitute the largest group of primary splenic malignant lymphomas, partially overlapping with splenic lymphoma with villous lymphocytes. Specific molecular markers for SMZL have yet to be defined. Because of the limited number of cases, the question of therapy for this group of lymphomas must remain open for the future.

摘要

由于对B细胞淋巴瘤手术切除脾脏标本进行组织学研究的情况较为罕见,不同类型脾低度B细胞淋巴瘤的识别和分类受到了阻碍。为了对最近描述的脾边缘区淋巴瘤(SMZL)进行特征描述,我们根据施密德定义的识别标准(施密德等人,《美国外科病理学杂志》1992年;16:455 - 66),对13例患有此类肿瘤的患者进行了一项调查。除了伴有绒毛状淋巴细胞的脾淋巴瘤外,原发性脾高度淋巴瘤、T细胞淋巴瘤以及其他已确认的低度B细胞淋巴瘤的继发性浸润均被排除。这样的选择产生了一组具有相似临床、组织学、免疫组化和分子特征的同质肿瘤群体。我们的研究表明,识别它们的关键参数是形态学方面的,包括宏观微结节性以及白髓和红髓浸润的持续存在、边缘区模式和浆细胞分化。在任何病例中均未检测到t(14;18)或PRAD - 1/细胞周期蛋白D1过表达。临床上,肿瘤广泛分布且病程迁延。在我们的病例中,SMZL的淋巴结浸润在形态上与单核样B细胞淋巴瘤相似。SMZL可能构成原发性脾恶性淋巴瘤的最大群体,部分与伴有绒毛状淋巴细胞的脾淋巴瘤重叠。SMZL的特异性分子标志物尚未确定。由于病例数量有限,这组淋巴瘤的治疗问题在未来仍有待探讨。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验